
11 - 50 employees
Founded 2017
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Akero Therapeutics is a company pioneering novel therapies to transform the lives of people living with serious metabolic diseases. Their flagship program, Efruxifermin (EFX), is aimed at treating metabolic dysfunction-associated steatohepatitis (MASH) and is currently undergoing multiple clinical trials. Akero is committed to advancing medicine in the field of metabolic diseases and has a strong focus on research, development, and clinical studies.
📡 We watch Akero Therapeutics's careers page
Every 2 hours
how often we check
2
roles posted in the last 30 days
About 22 days
usual time to fill a role
14
roles closed in the last year
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 October 27
Clinical Program Manager leading global Phase 3 study operations for Akero Therapeutics’ metabolic disease medicines. Managing CROs, timelines, risks, compliance, and cross-functional execution.
🇺🇸 United States – Remote
💵 $152.7k - $267.3k / year
⏰ Full Time
🟠 Senior
🏥 Clinical Operations
👻 Ghost score 0%
🕒 August 20
Clinical development director advancing Akero’s MASH treatment, efruxifermin, through Phase 3 trials. Leading medical monitoring, regulatory submissions, data analysis, and scientific disclosures.
🇺🇸 United States – Remote
💵 $187.1k - $327.5k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 35%